Danone 2023 Profit Fell; 2024 Guidance in Line With Midterm Targets
By Kimberley Kao
Danone reported a fall in full-year profit and sales while saying guidance for 2024 remains in line with its mid-term targets.
The French food company said Thursday that 2023 net profit was 881 million euros ($953.1 million) compared with EUR959 million in the previous year. Recurring net income, which excludes exceptional items, was EUR2.28 billion, up 3.5% compared with the same period a year earlier.
The recurring operating margin for the year was 12.6%, up 40 basis points compared with the previous year, with gains in volume, mix and price partially offset by input-cost inflation net of productivity, the company said.
Full-year sales was EUR27.62 billion, down from EUR27.66 billion in 2022. On a like-for-like basis, sales rose 7.0%, with price up 7.4% and volume/mix down 0.4%.
In the fourth quarter, consolidated sales were EUR6.66 billion, down from EUR7.01 billion a year ago.
Danone said its 2024 guidance was in line with its mid-term ambitions, with like-for-like sales growth expected between 3% and 5%, and recurring operating margin expected to post moderate improvement.
The board of directors will propose a dividend of EUR2.10 a share for 2023, up 5.0% from the previous year.
Write to Kimberley Kao at kimberley.kao@wsj.com
(END) Dow Jones Newswires
February 22, 2024 01:42 ET (06:42 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?